tirzepatide vs semaglutide reviews vs. for Weight Loss Elevate Health GLP-1 Program Analysis:

In extremely rare instances, semaglutide has been associated with an increased risk of certain types of thyroid cancer, particularly in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Readers should request written dosing instructions and confirm syringe size with the prescriber or pharmacy before injecting

Some patients report improvement in energy levels within several weeks of maintaining a stable dose, while others may experience longer periods of adaptation

Many gastrointestinal side effects of tirzepatide, including reflux symptoms, tend to diminish over time as patients develop tolerance

Whether this applies to retatrutide is not yet established